期刊文献+

儿童原发性肾病综合征血清酰化刺激蛋白及补体C3水平的变化 被引量:1

Levels of serum acylation-stimulating protein and C3 in children with primary nephrotic syndrome
原文传递
导出
摘要 目的观察原发性肾病综合征(PNS)患儿血清酰化刺激蛋白(ASP)、补体C3水平的变化以及与血脂的关系。方法分别检测35例未经治疗的PNS患儿(蛋白尿组)和25例缓解期PNS患儿(缓解组)空腹血清ASP、C3、白蛋白及血脂水平,并与35例体重指数相匹配的正常儿童(对照组)进行比较。结果蛋白尿组血清ASP水平(101±22 nmol/L)高于缓解组(32±8 nmol/L)及对照组(33±8 nmol/L)(P<0.01),而血清C3水平在3组之间差异无统计学意义。蛋白尿组血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)、载脂蛋白B(apoB)水平明显升高,血清白蛋白(ALB)水平明显降低,与缓解组和对照组比较,差异有统计学意义(P<0.01)。蛋白尿组血清ASP浓度与补体C3、TG水平呈显著正相关(r=0.661,0.354;P<0.05),补体C3与TG无显著相关性(r=0.319,P>0.05)。结论 PNS患儿血清ASP水平升高,推测与机体对抗高脂血症有关。 Objective To study serum acylation-stimulating protein(ASP) and complement 3(C3) levels and their relationship with blood lipids in children with primary nephrotic syndrome(PNS).Methods Blood samples were obtained from 35 PNS children with proteinuria,25 children with PNS at remission and 35 body mass index-matched healthy children(control group).Fasting serum ASP,C3,albumin and blood lipids were measured.Results The serum ASP levels in the proteinuria group(101±22 nmol/L) were significantly higher than those in the remission group(32±8 nmol/L) and the control group(33± 8 nmol/L)(P0.01).Serum C3 levels were not significantly different among the three groups.The serum concentrations of total cholesterol,triglyceride,low density lipoprotein and apolipoprotein B increased,in contrast,serum albumin level decreased significantly in the proteinuria group when compared with the remission and the control groups.Serum ASP levels were positively correlated with serum C3(r=0.661;P0.05) and triglyceride levels(r=0.354;P0.05),whereas serum C3 levels were not correlated with serum triglyceride levels(r=0.319,P0.05).Conclusions The increased serum ASP level may be associated with a complemental mechanism against hyperlipidemia in children with PNS.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2011年第10期817-819,共3页 Chinese Journal of Contemporary Pediatrics
关键词 酰化刺激蛋白 补体3 血脂 原发性肾病综合征 儿童 Acylation-stimulating protein Complement 3 Blood lipid Primary nephrotic syndrome Child
  • 相关文献

参考文献12

  • 1Warwick GL, Packard CJ. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications [J]. Miner Electrolyte Metab, 1993, 19(3): 115-126.
  • 2王建军,杨锡强,魏钰书,赵耀,罗晓菊,李睿.瘦素及可溶性瘦素受体在原发性肾病综合征患儿血脂升高中的作用[J].实用儿科临床杂志,2005,20(11):1098-1100. 被引量:3
  • 3中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量:1533
  • 4Hogg RJ, Portman R J, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE) [ J ]. Pediatrics, 2000, 105 (6) : 1242- 1249.
  • 5Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF. Hyperlipidaemia in untreated nephritic syndrome, increased production or decreased removal? [ J]. Clin Chim Acta, 1981, 117(3) : 317-323.
  • 6Hu P, Lu L, Hu B, Du PF. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephritic syndrome[J]. Scand J Clin Lab Invest, 2009, 69 (6) : 680-686.
  • 7Zoceali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease[J]. J Am Soe Nephrol, 2002, 13( 1 ) : 134-141.
  • 8王道昉,康玉梅,战美丽,李萍,田春莉.血脂动态监测在肾病综合征中的诊断价值[J].中国当代儿科杂志,2001,3(2):181-182. 被引量:1
  • 9Cianflone K, Maslowska M, Snideman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions[J]. Serain Cell Dev Biol, 1999, 10(1) : 31-41.
  • 10Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents[J]. Biochim Biophys Acta, 2003, 1609(2) : 127-143.

二级参考文献12

  • 1张美和,刘效兰,李时莲.单纯性肥胖儿童黑色棘皮症与胰岛素抵抗性及细胞因子的关系[J].实用儿科临床杂志,2004,19(10):851-853. 被引量:4
  • 2宋红梅,魏珉.肾病综合征与高脂血症[J].中华儿科杂志,1996,34(5):353-355. 被引量:7
  • 3宋红梅,魏珉.原发肾病综合征患儿的血清脂质水平[J].中华儿科杂志,1996,34(4):267-269. 被引量:4
  • 4Ozata M, Oktenli C, Gulec M, et al. Increased fasting plasma acylation-stimulating protein concentration in nephrotic syndrome[J]. J Clin Endocrinol Metab ,2002,87(2) :853 - 885.
  • 5Kratzsch J, Lammert A, Bottner A, et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence[J]. J Clin Endocrinol Metab, 2002,87 (10) :4587 - 4594.
  • 6Chart JL, Bluher S, Yiannakouris N, et al. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans[J]. Diabetes,2002,51(7):2105-2112.
  • 7Lahlou N, Issad T, Lebouc Y, et al. Mutations in the human leptin and receptor genes as models of serum leptin receptor regulation[J]. Diabetes, 2002,51 : 1980 - 1985.
  • 8Javor ED, Moran SA, Young JR, et al. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy[J]. J Clin Endocrinol Metab, 2004,89 (7) : 3199 - 3207.
  • 9夏新献 陈荣华 王宝琳.关于小儿肾小球疾病的临床分类和治疗的修改意见[J].中华儿科杂志,1991,19(4):241-241.
  • 10Thabet MA, Scalcedo JR, Chan JC. Hyperlipidemia in childhood nephrotic syndrome[J]. Pediatr Nephrol, 1993, 28(7): 557-559.

共引文献1533

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部